Maturation of dendritic cells in the presence of living, apoptotic and necrotic tumour cells derived from squamous cell carcinoma of head and neck

Oral Oncology

Volumn 41, Issue 1, 2005, Pages 17-24

  Kacani, Laco ^a   Wurm, Martin ^a   Schwentner, Ilona ^a   Andrle, Jan ^a   Schennach, Harald ^a   Sprinzl, Georg M ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Antigen presentation; Cytokines; Dendritic cells; Head and neck squamous cell carcinoma; T lymphocytes; Tumour antigen

Indexed keywords

CANCER VACCINE; INTERLEUKIN 12;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL DEATH; CELL LINE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE RELEASE; DENDRITIC CELL; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR CELL; VACCINATION;

ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; APOPTOSIS; CANCER VACCINES; CARCINOMA, SQUAMOUS CELL; CELL DIFFERENTIATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOPHENOTYPING; INTERLEUKIN-10; INTERLEUKIN-12; NECROSIS; PHAGOCYTOSIS; TUMOR CELLS, CULTURED;

EID: 10644278651     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oraloncology.2004.05.006     Document Type: Article

References (20)

1. G.M. Sprinzl, B. Hussl, and P. Obrist Dendritic cells in precancerous lesions of the larynx Laryngoscope 110 2000 13 18
2. G.M. Sprinzl, L. Kacani, A. Schrott-Fischer, N. Romani, and W.F. Thumfart Dendritic cell vaccines for cancer therapy Cancer Treat. Rev. 27 2001 247 255
3. R.M. Steinman The dendritic cell system and its role in immunogenicity Annu. Rev. Immunol. 9 1991 271 296
4. D.N. Hart Dendritic cells: unique leukocyte populations which control the primary immune response Blood 90 1997 3245 3287
5. J. Banchereau, F. Briere, and C. Caux Immunobiology of dendritic cells Annu. Rev. Immunol. 18 2000 767 811
6. Y. Kotera, K. Shimizu, and J.J. Mule Comparative analysis of necrotic and apoptotic tumour cells as a source of antigen(s) in dendritic cell-based immunization Cancer Res. 61 2001 8105 8109
7. M.L. Albert, B. Sauter, and N. Bhardwaj Dendritic cells acquire antigen from apoptotic cells and induce class I-restricted CTLs Nature 392 1998 86 89
8. B. Sauter, M.L. Albert, L. Francisco, M. Larsson, S. Somersan, and S. Bhardwaj Consequences of cell death: exposure to necrotic tumour cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells J. Exp. Med. 191 2000 423 433
9. S. Gallucci, M. Lolkema, and P. Matzinger Natural adjuvants: endogenous activators of dendritic cells Nat. Med. 5 1999 1249 1255
10. L. Kacani, I. Frank, and M. Spruth Dendritic cells transmit human immunodeficiency virus type 1 to monocytes and monocyte-derived macrophages J. Virol. 72 1998 6671 6677
11. L. Fong, and E.G. Engleman Dendritic cells in cancer immunotherapy Annu. Rev. Immunol. 18 2000 245 273
12. E.G. Engleman Dendritic cell-based cancer immunotherapy Semin. Oncol. 30 2003 23 29
13. G. Schuler, B. Schuler-Thurner, and R.M. Steinman The use of dendritic cells in cancer immunotherapy Curr. Opin. Immunol. 15 2003 138 147
14. R.M. Steinman, and M. Dhodapkar Active immunization against cancer with dendritic cells: the near future Int. J. Cancer 94 2001 459 473
15. S. Basu, R.J. Binder, R. Suto, K.M. Anderson, and P.K. Srivastava Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-kappa B pathway Int. Immunol. 12 2000 1539 1546
16. R.M. Steinman, S. Turley, I. Mellman, and K. Inaba The induction of tolerance by dendritic cells that have captured apoptotic cells J. Exp. Med. 191 2000 411 416
17. S. Somersan, M. Larsson, J.F. Fonteneau, S. Basu, P. Srivastava, and N. Bhardwaj Primary tumour tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells J. Immunol. 167 2001 4844 4852
18. P. Matzinger The danger model: a renewed sense of self Science 296 2002 301 305
19. T.K. Hoffmann, D.J. Loftus, and K. Nakano The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53 (264-272) epitope J. Immunol. 168 2002 1338 1347
20. L. Kacani, M. Wurm, H. Schennach, I. Braun, J. Andrle, and G.M. Sprinzl Immunosuppressive effects of soluble factors secreted by head and neck squamous cell carcinoma on dendritic cells and T lymphocytes Oral Oncol. 39 2003 672 679